These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 18379458)

  • 1. [Neuromidin in the treatment of vascular cognitive disorders].
    Golovkova MS; Zakharov VV; Lifshits MIu; Iakhno NN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(9):20-6. PubMed ID: 18379458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neuromidin in the treatment of cognitive impairment in the early rehabilitation period of ischemic stroke].
    Pustokhanova LV; Morozova EM; Selivokhina OI; Shiliaeva EA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(3 Pt 2):47-52. PubMed ID: 23612399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The use of neuromidin in patients with minor ischemic stroke].
    Maksimova MIu; Sharov MN; Sineva NA; Vodop'ianov NP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(8 Pt 2):35-40. PubMed ID: 22224243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Noben (idebenone) in the treatment of dementia and memory impairment without dementia].
    Voronkova KV; Meleshkov MN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(4):27-32. PubMed ID: 18454094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cognitive disorders in the early rehabilitation period of ischemic stroke and possibilities of their treatment with neuromidin].
    Pustokhanova LV; Morozova EM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(4 Pt 2):23-7. PubMed ID: 23120773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neuromidin in mixed vascular and Alzheimer's dementia].
    Damulin IV; Stepkina DA; Lokshina AB
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(2):40-3. PubMed ID: 21350422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of the anticholinesterase drug neuromidin in patients with schizophrenia with marked neurocognitive deficits].
    Morozova MA; Beniashvili AG; Rupchev GE; Lepilkina TA; Starostin DS; Brusov OS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(11):28-35. PubMed ID: 19008797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicenter, open-label, 24-week follow-up study for efficacy on cognitive function of donepezil in Binswanger-type subcortical vascular dementia.
    Kwon JC; Kim EG; Kim JW; Kwon OD; Yoo BG; Yi HA; Choi NC; Ahn SY; Lee BH; Kang MJ; Choi DS;
    Am J Alzheimers Dis Other Demen; 2009; 24(4):293-301. PubMed ID: 19383979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experience in clinical use of tanakan in the treatment of the syndrome of mild cognitive impairment].
    Gavrilova SI; Fedorova IaB; Roshchina IF; Kolykhalov IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(10):42-6. PubMed ID: 17117673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experience of joint administration of neuromidin and ovestin for correcting cognitive disorders in females with hypoestrogenic syndrome].
    Fedotova IuO
    Eksp Klin Farmakol; 2010 Oct; 73(10):34-6. PubMed ID: 21254512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Vinpotropil in the treatment of dyscirculatory encephalopathy with cognitive impairment without dementia].
    Zakharov VV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(11 Pt 1):13-6. PubMed ID: 21183916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Akatinol memantine in the therapy of cognitive disorders in Parkinson's disease].
    Puzin MN; Krivonos OV; Kozhevnikova ZhV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(1):26-9. PubMed ID: 17310793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of acatinol memantine in mild cognitive disorder].
    Levin OS; Iunishchenko NA; Dudarova MA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(7):36-42. PubMed ID: 19672236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cognitive enhancement effect of piracetam in patients with mild cognitive impairment and dementia].
    Tariska P; Paksy A
    Orv Hetil; 2000 May; 141(22):1189-93. PubMed ID: 10853348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cerebrolysin treatment of mild cognitive impairment of vascular genesis].
    Damulin IV; Mkhitarian EA; Koberskaia NN
    Ter Arkh; 2007; 79(6):65-9. PubMed ID: 17684971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between antihypertensive drug therapy and cognitive function in elderly hypertensive patients with memory complaints.
    Hanon O; Pequignot R; Seux ML; Lenoir H; Bune A; Rigaud AS; Forette F; Girerd X
    J Hypertens; 2006 Oct; 24(10):2101-7. PubMed ID: 16957572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A study of the tolerability and effectiveness of nicardipine retard in cognitive deterioration of vascular origin].
    González-González JA; Lozano R
    Rev Neurol; 2000 Apr 16-30; 30(8):719-28. PubMed ID: 10893735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acetyl-L-carnitine (carnicetine) in the treatment of early stages of Alzheimer's disease and vascular dementia].
    Gavrilova SI; Kalyn IaB; Kolykhalov IV; Roshchina IF; Selezneva ND
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(9):16-22. PubMed ID: 22027664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [An experimental, randomized, double-blind, placebo-controlled clinical trial to infestigate the effect of nicardipine on cognitive function in patients with vascular dementia. Spanish group of nicardipine study in vascular dementia].
    Rev Neurol; 1999 May 1-15; 28(9):835-45. PubMed ID: 10390744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Spanish version of the Addenbrooke's Cognitive Examination - Revised (ACE-R) in subcortical ischemic vascular dementia.
    Raimondi C; Gleichgerrcht E; Richly P; Torralva T; Roca M; Camino J; Manes F
    J Neurol Sci; 2012 Nov; 322(1-2):228-31. PubMed ID: 22959102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.